Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Insulin Pump Market to Reach $20.91 Billion by 2027


DUBLIN, Oct. 6, 2022 /PRNewswire/ -- The "Global Insulin Pump Market, Users, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to  ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

According to the publisher, Global Insulin Pump Market is estimated to reach US$ 20.91 Billion by 2027. Insulin pumps are compact electronic medical devices that can be fastened to a belt, hidden in a pocket, or worn under clothing. Besides, to regulate the rise in blood glucose levels, the pump delivers controlled quantities of insulin into the body at regular intervals, based on the consumer's basal and bolus rates.

Furthermore, it works with a needle and a flexible catheter to inject insulin straight into the fatty tissue, subsequently taped and fastened. In addition, insulin pumps help people with type 1 and type 2 diabetes by giving them more food options and eating schedule flexibility and reducing the number of injections they need.

Global Insulin Pump Market Size Is Expanding with a CAGR Of 5.20% During 2021-2027

The rising prevalence of diabetes and increased health awareness have been prevalent. Furthermore, because diabetes can lead to other chronic illnesses, including kidney failure, stroke, paralysis, and blindness, manufacturers focus more on developing adaptable and economical technologies like insulin pumps. The demand for efficient insulin pumps has also increased due to the development of very accurate glucose sensors and blood monitoring systems. Furthermore, recent market expansion has been aided by factors such as rising per capita healthcare spending and increased research and development for improving the functionality of insulin pumps.

Competitive Landscape

The Global Insulin Pump Market is highly competitive, competing with only a few companies. Medtronic, Insulet Corporation, Tandem Diabetes Care, and Roche are the critical players profiled in our analysis. These companies control a large percentage of the worldwide market.

In addition, they are constantly expanding into new markets to generate new revenue streams and enhance old ones. The acts of these market participants will create a competitive environment, forcing businesses to experiment with the latest technology to keep their products unique. Companies are also collaborating to expand their technological understanding and reduce the time it takes to develop a product.

The above-mentioned countries have been covered from 3 viewpoints1. Diabetes Population

2. Insulin Pump Analysis

3. Reimbursement Policies on Insulin Pump

Countries - Insulin Pump Market & Users, Diabetes Type 1 & 2 Population of all the 15 Countries Covered in the Report

1. United States
2. United Kingdom
3. Israel
4. Germany
5. Netherlands
6. Sweden
7. France
8. Switzerland
9. Australia
10. Japan
11. Canada
12. Kuwait
13. Saudi Arabia
14. Italy
15. Spain

Differentiation Points, Products Available Worldwide have been covered from 4 viewpoints

1. Medtronic 530G with Enlite
2. InsuletOmniPod
3. Tandem t:slim
4. Roche Accu-Chek Combo

Company Insights

Companies Covered

1. Medtronic
2. Insulet Corporation
3. Tandem Diabetes Care
4. Roche


Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Global Insulin Pump Analysis

6. Global Insulin Pump Market & Volume Share Analysis

7. Training Model for Patients & HCP - of Medtronic, Insulet Corp & Tandem Diabetes Care

8. Differentiation Points of Insulin Pump Products Available Worldwide

9. United States

10. United Kingdom

11. Israel

12. Germany

13. Netherlands

14. Sweden

15. France

16. Switzerland

17. Australia

18. Japan

19. Canada

20. Kuwait

21. Saudi Arabia

22. Italy

23. Spain

24. Company Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/df09pv

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: